Related Experiment Video

Updated: May 4, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K

Teaching an old dog new tricks: drug repositioning in small cell lung cancer

Jing Wang1, Lauren Averett Byers

  • 11Departments of Bioinformatics and Computational Biology and 2Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Cancer Discovery
|December 12, 2013
PubMed

Insights

Researchers used biostatistical analysis to find new small cell lung cancer (SCLC) treatments. The study identified the antidepressant imipramine as a potential therapy for SCLC, highlighting drug repositioning

Area of Science:

  • Oncology
  • Pharmacology
  • Biostatistics

Background:

  • Small cell lung cancer (SCLC) remains a challenging malignancy with limited effective therapeutic options.
  • Drug repositioning offers a promising strategy to identify novel treatments for existing drugs.

Purpose of the Study:

  • To identify effective therapeutics for small cell lung cancer (SCLC) using biostatistical analysis.
  • To explore the potential of drug repositioning for SCLC treatment.

Main Methods:

  • Biostatistical analysis of large-scale datasets.
  • Identification of drug candidates with potential efficacy in SCLC.

Main Results:

  • The tricyclic antidepressant imipramine was identified as a potential therapeutic agent for SCLC.
  • The study provides evidence for the efficacy of imipramine in preclinical models of SCLC.

Conclusions:

  • Imipramine represents a novel therapeutic candidate for small cell lung cancer.
  • Drug repositioning holds significant potential for discovering new cancer treatments and therapies for other diseases.

More Related Videos

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

16.7K
Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

19.0K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.1K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K